Viemed Healthcare, Inc.
NASDAQ:VMDMedical - Devices
+$0.07 today
- Market cap
- $326.26M
- Beta
- 1.13
- P/E (TTM)
- 27.4
- EPS (TTM)
- $0.39
Volume 0.17M
Average 0.26M
Returns on capital
Viemed Healthcare, Inc. management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
10.6%
avg 22.9%
ROIC
8.3%
avg 18.8%
ROA
6.9%
avg 14.3%
Analysis
ROE is currently the strongest return metric at 10.6% versus its period average of 22.9%. 1 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
Casey Hoyt | Chief Executive Officer & Director | USD 1.11M | 49 | 13.27K | 0.03% |
Michael Moore | President | USD 973.49K | 49 | 1.59M | 4.14% |
William Todd Zehnder | Chief Operating Officer & Director | USD 967.91K | 51 | 8.95K | 0.02% |
Jerome Richard Cambre | Vice President of Sales | USD 553K | 55 | — | — |
Jeremy Trahan | Executive VP, General Counsel & Corporate Secretary | USD 539.41K | 56 | 3.59K | <0.01% |
Trae Paul Fitzgerald | Chief Financial Officer | USD 507.85K | 38 | — | — |
William Dana Frazier | Chief Medical Officer & Director | USD 53.04K | 68 | — | — |
Michael Freeman | Chief Business Development Officer | — | — | — | — |
Compensation is shown in the reported currency; data updated Nov 7, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Mar 20, 2026.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
9
$1.59M
Net Transaction Value
−$1.59M
Net selling
Most Active
Smokoff Timothy
5 transactions
Transactions sorted by date, descending.
| Type | |||
|---|---|---|---|
| Jun 25, 26Jun 25, 2026 | Frazier William Direct | Sell | $117.2K$117,200.00 |
| Jun 24, 26Jun 24, 2026 | Smokoff Timothy Direct | Sell | $57.1K$57,050.00 |
| Jun 24, 26Jun 24, 2026 | Smokoff Timothy Direct | Sell | $18.8K$18,781.28 |
| Jun 24, 26Jun 24, 2026 | Smokoff Timothy Direct | Sell | $38.7K$38,686.00 |
| Jun 24, 26Jun 24, 2026 | Smokoff Timothy Direct | Sell | $57.7K$57,650.00 |
| Jun 24, 26Jun 24, 2026 | Smokoff Timothy Direct | Sell | $57.8K$57,800.00 |
| Mar 20, 26Mar 20, 2026 | Moore Michael Indirect | Sell | $570.1K$570,050.00 |
| Mar 19, 26Mar 19, 2026 | Moore Michael Indirect | Sell | $370.5K$370,536.72 |
| Mar 18, 26Mar 18, 2026 | Moore Michael Indirect | Sell | $297.4K$297,389.40 |
Summary
Insiders reported 0 buys worth $0.00 and 9 sells worth $1.59M over the last 12 months. That adds up to net selling of $1.59M. Smokoff Timothy was the most active insider with 5 transactions.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +35.1% | +17.8% (3yr)2 analysts |
| Revenue | N/A | N/A | +24.9% | +12.2% (3yr)2 analysts |
| Net Income | N/A | N/A | +33.9% | +18.3% (3yr)2 analysts |
| EBIT | N/A | N/A | +35.9% | +20.1% (3yr)2 analysts |
Analysis
Recent growth has been strongest in EBIT at +35.9% over three years. Forward estimates point to EBIT at +20.1% (3yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Who does Viemed Healthcare, Inc. compete with?
Open similar companies to compare how their management teams allocate capital.
Questions
Management questions
Common questions about VMD's management, answered from reported figures.
Who manages VMD?
Viemed Healthcare, Inc. (VMD) lists 8 active executives. The top listed executive is Casey Hoyt, Chief Executive Officer & Director.
Are VMD insiders buying or selling?
Recent insider activity shows net selling of $5.31M.
Continue the stock analysis
Jump to another research area for this company.